Investor blasts Omega Protein's human nutrition diversification plans, calls for breakup, sale of company
Omega Protein Corporation has received a harsh critique of its diversification strategy from a major investor. Wynnefield Partners filed a Form 13D with the Securities and Exchange Commission calling for the company to seek alternatives—up to and...